Synopsis:
There is a significant improvement in microalbuminuria, serum β2-croglobulin, urine B2-microglobulin and serum cystatin C by Tanshinone IIA in the management of early renal damage in patients with type 2 diabetes. Hence, Tanshinone 11A might alleviate early renal damage from diabetic nephropathy.